Global Cell and Gene Therapy Manufacturing QC Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 20-Apr-2021
No. of pages: 121
Inquire Before Buying

Global Cell and Gene Therapy Manufacturing QC Scope and Market Size

Cell and Gene Therapy Manufacturing QC market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy Manufacturing QC market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Safety Testing

- Purity Testing

- Potency Testing

- Identity Testing

- Stability Testing

Segment by Application

- Precision Therapy

- Biological Research

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bio-Techne Corporation

- BioMerieux SA

- Catalent, Inc.

- Charles River Laboratories International Inc.

- Eurofins Scientific SE

- F. Hoffmann-La Roche Ltd

- Intertek Group plc

- Lonza Group AG

- Merck KGaA

- Sartorius AG

- SGS S.A.

- Sistemic Scotland Limited

- Thermo Fisher Scientific Inc.

- Vigene Biosciences, Inc.

- WuXi AppTec

Global Cell and Gene Therapy Manufacturing QC Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Safety Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Stability Testing
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Precision Therapy
1.3.3 Biological Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2016-2027)
2.2 Cell and Gene Therapy Manufacturing QC Growth Trends by Regions
2.2.1 Cell and Gene Therapy Manufacturing QC Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Share by Regions (2016-2021)
2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Regions (2022-2027)
2.3 Cell and Gene Therapy Manufacturing QC Industry Dynamic
2.3.1 Cell and Gene Therapy Manufacturing QC Market Trends
2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2016-2021)
3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2016-2021)
3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing QC Revenue
3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2020
3.5 Cell and Gene Therapy Manufacturing QC Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing QC Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing QC Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2016-2021)
4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2022-2027)
5 Cell and Gene Therapy Manufacturing QC Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2016-2021)
5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
6.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type
6.2.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
6.2.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
6.2.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application
6.3.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
6.3.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
6.3.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
6.4 North America Cell and Gene Therapy Manufacturing QC Market Size by Country
6.4.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
6.4.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
7.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type
7.2.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
7.2.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
7.2.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application
7.3.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
7.3.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
7.3.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
7.4 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country
7.4.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
7.4.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
9.2.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
9.2.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
9.3.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
9.3.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
9.4 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
9.4.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Details
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.1.5 Bio-Techne Corporation Recent Development
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Details
11.2.2 BioMerieux SA Business Overview
11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.2.5 BioMerieux SA Recent Development
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Details
11.3.2 Catalent, Inc. Business Overview
11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.3.5 Catalent, Inc. Recent Development
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Details
11.4.2 Charles River Laboratories International Inc. Business Overview
11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.4.5 Charles River Laboratories International Inc. Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Details
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.5.5 Eurofins Scientific SE Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Details
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Intertek Group plc
11.7.1 Intertek Group plc Company Details
11.7.2 Intertek Group plc Business Overview
11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.7.5 Intertek Group plc Recent Development
11.8 Lonza Group AG
11.8.1 Lonza Group AG Company Details
11.8.2 Lonza Group AG Business Overview
11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.8.5 Lonza Group AG Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.9.5 Merck KGaA Recent Development
11.10 Sartorius AG
11.10.1 Sartorius AG Company Details
11.10.2 Sartorius AG Business Overview
11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.10.5 Sartorius AG Recent Development
11.11 SGS S.A.
11.11.1 SGS S.A. Company Details
11.11.2 SGS S.A. Business Overview
11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.11.5 SGS S.A. Recent Development
11.12 Sistemic Scotland Limited
11.12.1 Sistemic Scotland Limited Company Details
11.12.2 Sistemic Scotland Limited Business Overview
11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.12.5 Sistemic Scotland Limited Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Details
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
11.14 Vigene Biosciences, Inc.
11.14.1 Vigene Biosciences, Inc. Company Details
11.14.2 Vigene Biosciences, Inc. Business Overview
11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.14.5 Vigene Biosciences, Inc. Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.15.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Safety Testing
Table 3. Key Players of Purity Testing
Table 4. Key Players of Potency Testing
Table 5. Key Players of Identity Testing
Table 6. Key Players of Stability Testing
Table 7. Global Cell and Gene Therapy Manufacturing QC Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cell and Gene Therapy Manufacturing QC Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cell and Gene Therapy Manufacturing QC Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing QC Market Share by Regions (2016-2021)
Table 11. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cell and Gene Therapy Manufacturing QC Market Share by Regions (2022-2027)
Table 13. Cell and Gene Therapy Manufacturing QC Market Trends
Table 14. Cell and Gene Therapy Manufacturing QC Market Drivers
Table 15. Cell and Gene Therapy Manufacturing QC Market Challenges
Table 16. Cell and Gene Therapy Manufacturing QC Market Restraints
Table 17. Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cell and Gene Therapy Manufacturing QC Market Share by Players (2016-2021)
Table 19. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2020)
Table 20. Ranking of Global Top Cell and Gene Therapy Manufacturing QC Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
Table 24. Date of Enter into Cell and Gene Therapy Manufacturing QC Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2016-2021)
Table 28. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cell and Gene Therapy Manufacturing QC Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2016-2021)
Table 32. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bio-Techne Corporation Company Details
Table 65. Bio-Techne Corporation Business Overview
Table 66. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product
Table 67. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 68. Bio-Techne Corporation Recent Development
Table 69. BioMerieux SA Company Details
Table 70. BioMerieux SA Business Overview
Table 71. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product
Table 72. BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 73. BioMerieux SA Recent Development
Table 74. Catalent, Inc. Company Details
Table 75. Catalent, Inc. Business Overview
Table 76. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 77. Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 78. Catalent, Inc. Recent Development
Table 79. Charles River Laboratories International Inc. Company Details
Table 80. Charles River Laboratories International Inc. Business Overview
Table 81. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product
Table 82. Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 83. Charles River Laboratories International Inc. Recent Development
Table 84. Eurofins Scientific SE Company Details
Table 85. Eurofins Scientific SE Business Overview
Table 86. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product
Table 87. Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 88. Eurofins Scientific SE Recent Development
Table 89. F. Hoffmann-La Roche Ltd Company Details
Table 90. F. Hoffmann-La Roche Ltd Business Overview
Table 91. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product
Table 92. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 93. F. Hoffmann-La Roche Ltd Recent Development
Table 94. Intertek Group plc Company Details
Table 95. Intertek Group plc Business Overview
Table 96. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product
Table 97. Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 98. Intertek Group plc Recent Development
Table 99. Lonza Group AG Company Details
Table 100. Lonza Group AG Business Overview
Table 101. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 102. Lonza Group AG Recent Development
Table 103. Merck KGaA Company Details
Table 104. Merck KGaA Business Overview
Table 105. Merck KGaA Cell and Gene Therapy Manufacturing QC Product
Table 106. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 107. Merck KGaA Recent Development
Table 108. Sartorius AG Company Details
Table 109. Sartorius AG Business Overview
Table 110. Sartorius AG Cell and Gene Therapy Manufacturing QC Product
Table 111. Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 112. Sartorius AG Recent Development
Table 113. SGS S.A. Company Details
Table 114. SGS S.A. Business Overview
Table 115. SGS S.A. Cell and Gene Therapy Manufacturing QC Product
Table 116. SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 117. SGS S.A. Recent Development
Table 118. Sistemic Scotland Limited Company Details
Table 119. Sistemic Scotland Limited Business Overview
Table 120. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product
Table 121. Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 122. Sistemic Scotland Limited Recent Development
Table 123. Thermo Fisher Scientific Inc. Company Details
Table 124. Thermo Fisher Scientific Inc. Business Overview
Table 125. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product
Table 126. Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 127. Thermo Fisher Scientific Inc. Recent Development
Table 128. Vigene Biosciences, Inc. Company Details
Table 129. Vigene Biosciences, Inc. Business Overview
Table 130. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 131. Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 132. Vigene Biosciences, Inc. Recent Development
Table 133. WuXi AppTec Company Details
Table 134. WuXi AppTec Business Overview
Table 135. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product
Table 136. WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 137. WuXi AppTec Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Manufacturing QC Market Share by Type: 2020 VS 2027
Figure 2. Safety Testing Features
Figure 3. Purity Testing Features
Figure 4. Potency Testing Features
Figure 5. Identity Testing Features
Figure 6. Stability Testing Features
Figure 7. Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2020 VS 2027
Figure 8. Precision Therapy Case Studies
Figure 9. Biological Research Case Studies
Figure 10. Cell and Gene Therapy Manufacturing QC Report Years Considered
Figure 11. Global Cell and Gene Therapy Manufacturing QC Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cell and Gene Therapy Manufacturing QC Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cell and Gene Therapy Manufacturing QC Market Share by Regions: 2020 VS 2027
Figure 14. Global Cell and Gene Therapy Manufacturing QC Market Share by Regions (2022-2027)
Figure 15. Global Cell and Gene Therapy Manufacturing QC Market Share by Players in 2020
Figure 16. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2020
Figure 18. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2016-2021)
Figure 19. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2022-2027)
Figure 20. North America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 22. North America Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 23. North America Cell and Gene Therapy Manufacturing QC Market Share by Country (2016-2027)
Figure 24. United States Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 28. Europe Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 29. Europe Cell and Gene Therapy Manufacturing QC Market Share by Country (2016-2027)
Figure 30. Germany Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Region (2016-2027)
Figure 40. China Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 48. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 49. Latin Americ
  • Global Medical Plasma Expressors Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 103
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Plasma Expressors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China marke......
  • Global Nasal Endoscopes Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 110
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Nasal Endoscopes is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market for Nas......
  • Global Medical Ceiling Pendants Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 113
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Ceiling Pendants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market......
  • Global Patient Remote Monitoring Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 95
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Patient Remote Monitoring Systems estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Patient Remote Monitoring Systems is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through......
  • Global Disposable Intravenous Line Connectors Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 108
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Disposable Intravenous Line Connectors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Th......
  • Global Medical Ultrasound Machines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 129
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Ultrasound Machines is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China mar......
  • Global Medical Thermoplastic Splints Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 131
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Thermoplastic Splints is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China m......
  • Global Medical Disposable Isolation Gowns Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 114
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Disposable Isolation Gowns is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The Ch......
  • Global Disposable Surgical Caps Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 126
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Disposable Surgical Caps is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs